Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths ...
Surprising research strongly suggests semaglutide can help fight substance use disorder. Why aren't we using it?